カテゴリー： LP Information, 世界, 医療/バイオ

世界の鼻腔内治療薬＆ワクチン送達装置市場予測 2023年-2029年

◆英語タイトル：Global Intranasal Drug And Vaccine Delivery Device Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU7977）◆商品コード：LP23JU7977
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：94
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の鼻腔内治療薬＆ワクチン送達装置市場」は、過去の販売実績から2022年の世界の鼻腔内治療薬＆ワクチン送達装置の総販売量を検討し、2023年から2029年の予測される鼻腔内治療薬＆ワクチン送達装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の鼻腔内治療薬＆ワクチン送達装置の市場規模を掲載し、XXX百万米ドル規模の世界の鼻腔内治療薬＆ワクチン送達装置市場の詳細な分析を提供します。本インサイトレポートは、世界の鼻腔内治療薬＆ワクチン送達装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の鼻腔内治療薬＆ワクチン送達装置市場における各社の独自のポジションをより深く理解するために、鼻腔内治療薬＆ワクチン送達装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の鼻腔内治療薬＆ワクチン送達装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。鼻腔内治療薬＆ワクチン送達装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。鼻腔内治療薬＆ワクチン送達装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。鼻腔内治療薬＆ワクチン送達装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

鼻腔内治療薬＆ワクチン送達装置の世界主要メーカーとしては、GlaxoSmithKline、 Teva Pharmaceuticals、 Aptar Pharma、 UCB、 Teleflex、 3M、 Bespak、 OptiNose、 Intersectなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の鼻腔内治療薬＆ワクチン送達装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では鼻腔内治療薬＆ワクチン送達装置市場をセグメンテーションし、種類別 (粉末送達装置、液体送達装置、加圧式定量吸入器、その他)、用途別 (呼吸器疾患、神経疾患、ワクチン接種、疼痛管理、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：粉末送達装置、液体送達装置、加圧式定量吸入器、その他

・用途別区分：呼吸器疾患、神経疾患、ワクチン接種、疼痛管理、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の鼻腔内治療薬＆ワクチン送達装置市場の10年間の市場状況・展望は？
・世界および地域別に見た鼻腔内治療薬＆ワクチン送達装置市場成長の要因は何か？
・鼻腔内治療薬＆ワクチン送達装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・鼻腔内治療薬＆ワクチン送達装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：鼻腔内治療薬＆ワクチン送達装置の年間販売量2018-2029、地域別現状・将来分析
・鼻腔内治療薬＆ワクチン送達装置の種類別セグメント：粉末送達装置、液体送達装置、加圧式定量吸入器、その他
・鼻腔内治療薬＆ワクチン送達装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・鼻腔内治療薬＆ワクチン送達装置の用途別セグメント：呼吸器疾患、神経疾患、ワクチン接種、疼痛管理、その他
・鼻腔内治療薬＆ワクチン送達装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の鼻腔内治療薬＆ワクチン送達装置市場
・企業別のグローバル鼻腔内治療薬＆ワクチン送達装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の鼻腔内治療薬＆ワクチン送達装置の年間売上：2018-2023年の売上、市場シェア
・企業別の鼻腔内治療薬＆ワクチン送達装置販売価格
・主要企業の鼻腔内治療薬＆ワクチン送達装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

鼻腔内治療薬＆ワクチン送達装置の地域別レビュー
・地域別の鼻腔内治療薬＆ワクチン送達装置市場規模2018-2023：年間販売量、売上
・主要国別の鼻腔内治療薬＆ワクチン送達装置市場規模2018-2023：年間販売量、売上
・南北アメリカの鼻腔内治療薬＆ワクチン送達装置販売の成長
・アジア太平洋の鼻腔内治療薬＆ワクチン送達装置販売の成長
・ヨーロッパの鼻腔内治療薬＆ワクチン送達装置販売の成長
・中東・アフリカの鼻腔内治療薬＆ワクチン送達装置販売の成長

南北アメリカ市場
・南北アメリカの国別の鼻腔内治療薬＆ワクチン送達装置販売量、売上（2018-2023）
・南北アメリカの鼻腔内治療薬＆ワクチン送達装置の種類別販売量
・南北アメリカの鼻腔内治療薬＆ワクチン送達装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の鼻腔内治療薬＆ワクチン送達装置販売量、売上（2018-2023）
・アジア太平洋の鼻腔内治療薬＆ワクチン送達装置の種類別販売量
・アジア太平洋の鼻腔内治療薬＆ワクチン送達装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の鼻腔内治療薬＆ワクチン送達装置販売量、売上（2018-2023）
・ヨーロッパの鼻腔内治療薬＆ワクチン送達装置の種類別販売量
・ヨーロッパの鼻腔内治療薬＆ワクチン送達装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の鼻腔内治療薬＆ワクチン送達装置販売量、売上（2018-2023）
・中東・アフリカの鼻腔内治療薬＆ワクチン送達装置の種類別販売量
・中東・アフリカの鼻腔内治療薬＆ワクチン送達装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・鼻腔内治療薬＆ワクチン送達装置の製造コスト構造分析
・鼻腔内治療薬＆ワクチン送達装置の製造プロセス分析
・鼻腔内治療薬＆ワクチン送達装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・鼻腔内治療薬＆ワクチン送達装置の主要なグローバル販売業者
・鼻腔内治療薬＆ワクチン送達装置の主要なグローバル顧客

地域別の鼻腔内治療薬＆ワクチン送達装置市場予測レビュー
・地域別の鼻腔内治療薬＆ワクチン送達装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・鼻腔内治療薬＆ワクチン送達装置の種類別市場規模予測
・鼻腔内治療薬＆ワクチン送達装置の用途別市場規模予測

主要企業分析
GlaxoSmithKline、 Teva Pharmaceuticals、 Aptar Pharma、 UCB、 Teleflex、 3M、 Bespak、 OptiNose、 Intersect
・企業情報
・鼻腔内治療薬＆ワクチン送達装置製品
・鼻腔内治療薬＆ワクチン送達装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
LPI (LP Information)’ newest research report, the “Intranasal Drug And Vaccine Delivery Device Industry Forecast” looks at past sales and reviews total world Intranasal Drug And Vaccine Delivery Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Intranasal Drug And Vaccine Delivery Device sales for 2023 through 2029. With Intranasal Drug And Vaccine Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intranasal Drug And Vaccine Delivery Device industry.
This Insight Report provides a comprehensive analysis of the global Intranasal Drug And Vaccine Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intranasal Drug And Vaccine Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intranasal Drug And Vaccine Delivery Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intranasal Drug And Vaccine Delivery Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intranasal Drug And Vaccine Delivery Device.
The global Intranasal Drug And Vaccine Delivery Device market size is projected to grow from US$ 1118.1 million in 2022 to US$ 1517.6 million in 2029; it is expected to grow at a CAGR of 1517.6 from 2023 to 2029.
North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 86% combined market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Intranasal Drug And Vaccine Delivery Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Powder Delivery Device
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Others
Segmentation by application
Respiratory Disorders
Neurological Disorder
Vaccination
Pain Management
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
GlaxoSmithKline
Teva Pharmaceuticals
Aptar Pharma
UCB
Teleflex
3M
Bespak
OptiNose
Intersect
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intranasal Drug And Vaccine Delivery Device market?
What factors are driving Intranasal Drug And Vaccine Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intranasal Drug And Vaccine Delivery Device market opportunities vary by end market size?
How does Intranasal Drug And Vaccine Delivery Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intranasal Drug And Vaccine Delivery Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Intranasal Drug And Vaccine Delivery Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Intranasal Drug And Vaccine Delivery Device by Country/Region, 2018, 2022 & 2029
2.2 Intranasal Drug And Vaccine Delivery Device Segment by Type
2.2.1 Powder Delivery Device
2.2.2 Liquid Delivery Device
2.2.3 Pressurized Metered Dose Inhaler
2.2.4 Others
2.3 Intranasal Drug And Vaccine Delivery Device Sales by Type
2.3.1 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
2.3.2 Global Intranasal Drug And Vaccine Delivery Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Intranasal Drug And Vaccine Delivery Device Sale Price by Type (2018-2023)
2.4 Intranasal Drug And Vaccine Delivery Device Segment by Application
2.4.1 Respiratory Disorders
2.4.2 Neurological Disorder
2.4.3 Vaccination
2.4.4 Pain Management
2.4.5 Others
2.5 Intranasal Drug And Vaccine Delivery Device Sales by Application
2.5.1 Global Intranasal Drug And Vaccine Delivery Device Sale Market Share by Application (2018-2023)
2.5.2 Global Intranasal Drug And Vaccine Delivery Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Intranasal Drug And Vaccine Delivery Device Sale Price by Application (2018-2023)
3 Global Intranasal Drug And Vaccine Delivery Device by Company
3.1 Global Intranasal Drug And Vaccine Delivery Device Breakdown Data by Company
3.1.1 Global Intranasal Drug And Vaccine Delivery Device Annual Sales by Company (2018-2023)
3.1.2 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Company (2018-2023)
3.2 Global Intranasal Drug And Vaccine Delivery Device Annual Revenue by Company (2018-2023)
3.2.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Company (2018-2023)
3.2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Company (2018-2023)
3.3 Global Intranasal Drug And Vaccine Delivery Device Sale Price by Company
3.4 Key Manufacturers Intranasal Drug And Vaccine Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intranasal Drug And Vaccine Delivery Device Product Location Distribution
3.4.2 Players Intranasal Drug And Vaccine Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intranasal Drug And Vaccine Delivery Device by Geographic Region
4.1 World Historic Intranasal Drug And Vaccine Delivery Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Intranasal Drug And Vaccine Delivery Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Intranasal Drug And Vaccine Delivery Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Intranasal Drug And Vaccine Delivery Device Market Size by Country/Region (2018-2023)
4.2.1 Global Intranasal Drug And Vaccine Delivery Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Intranasal Drug And Vaccine Delivery Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Intranasal Drug And Vaccine Delivery Device Sales Growth
4.4 APAC Intranasal Drug And Vaccine Delivery Device Sales Growth
4.5 Europe Intranasal Drug And Vaccine Delivery Device Sales Growth
4.6 Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Growth
5 Americas
5.1 Americas Intranasal Drug And Vaccine Delivery Device Sales by Country
5.1.1 Americas Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023)
5.1.2 Americas Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023)
5.2 Americas Intranasal Drug And Vaccine Delivery Device Sales by Type
5.3 Americas Intranasal Drug And Vaccine Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intranasal Drug And Vaccine Delivery Device Sales by Region
6.1.1 APAC Intranasal Drug And Vaccine Delivery Device Sales by Region (2018-2023)
6.1.2 APAC Intranasal Drug And Vaccine Delivery Device Revenue by Region (2018-2023)
6.2 APAC Intranasal Drug And Vaccine Delivery Device Sales by Type
6.3 APAC Intranasal Drug And Vaccine Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intranasal Drug And Vaccine Delivery Device by Country
7.1.1 Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023)
7.1.2 Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023)
7.2 Europe Intranasal Drug And Vaccine Delivery Device Sales by Type
7.3 Europe Intranasal Drug And Vaccine Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intranasal Drug And Vaccine Delivery Device by Country
8.1.1 Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Type
8.3 Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intranasal Drug And Vaccine Delivery Device
10.3 Manufacturing Process Analysis of Intranasal Drug And Vaccine Delivery Device
10.4 Industry Chain Structure of Intranasal Drug And Vaccine Delivery Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intranasal Drug And Vaccine Delivery Device Distributors
11.3 Intranasal Drug And Vaccine Delivery Device Customer
12 World Forecast Review for Intranasal Drug And Vaccine Delivery Device by Geographic Region
12.1 Global Intranasal Drug And Vaccine Delivery Device Market Size Forecast by Region
12.1.1 Global Intranasal Drug And Vaccine Delivery Device Forecast by Region (2024-2029)
12.1.2 Global Intranasal Drug And Vaccine Delivery Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intranasal Drug And Vaccine Delivery Device Forecast by Type
12.7 Global Intranasal Drug And Vaccine Delivery Device Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Aptar Pharma
13.3.1 Aptar Pharma Company Information
13.3.2 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.3.3 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aptar Pharma Main Business Overview
13.3.5 Aptar Pharma Latest Developments
13.4 UCB
13.4.1 UCB Company Information
13.4.2 UCB Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.4.3 UCB Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 UCB Main Business Overview
13.4.5 UCB Latest Developments
13.5 Teleflex
13.5.1 Teleflex Company Information
13.5.2 Teleflex Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.5.3 Teleflex Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teleflex Main Business Overview
13.5.5 Teleflex Latest Developments
13.6 3M
13.6.1 3M Company Information
13.6.2 3M Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.6.3 3M Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 3M Main Business Overview
13.6.5 3M Latest Developments
13.7 Bespak
13.7.1 Bespak Company Information
13.7.2 Bespak Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.7.3 Bespak Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bespak Main Business Overview
13.7.5 Bespak Latest Developments
13.8 OptiNose
13.8.1 OptiNose Company Information
13.8.2 OptiNose Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.8.3 OptiNose Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 OptiNose Main Business Overview
13.8.5 OptiNose Latest Developments
13.9 Intersect
13.9.1 Intersect Company Information
13.9.2 Intersect Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
13.9.3 Intersect Intranasal Drug And Vaccine Delivery Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Intersect Main Business Overview
13.9.5 Intersect Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Intranasal Drug And Vaccine Delivery Device Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Intranasal Drug And Vaccine Delivery Device Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Powder Delivery Device
Table 4. Major Players of Liquid Delivery Device
Table 5. Major Players of Pressurized Metered Dose Inhaler
Table 6. Major Players of Others
Table 7. Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2018-2023) & (K Units)
Table 8. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
Table 9. Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2018-2023) & ($ million)
Table 10. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2018-2023)
Table 11. Global Intranasal Drug And Vaccine Delivery Device Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2018-2023) & (K Units)
Table 13. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2018-2023)
Table 14. Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2018-2023)
Table 15. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application (2018-2023)
Table 16. Global Intranasal Drug And Vaccine Delivery Device Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Intranasal Drug And Vaccine Delivery Device Sales by Company (2018-2023) & (K Units)
Table 18. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Company (2018-2023)
Table 19. Global Intranasal Drug And Vaccine Delivery Device Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Company (2018-2023)
Table 21. Global Intranasal Drug And Vaccine Delivery Device Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Intranasal Drug And Vaccine Delivery Device Producing Area Distribution and Sales Area
Table 23. Players Intranasal Drug And Vaccine Delivery Device Products Offered
Table 24. Intranasal Drug And Vaccine Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Intranasal Drug And Vaccine Delivery Device Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share Geographic Region (2018-2023)
Table 29. Global Intranasal Drug And Vaccine Delivery Device Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Intranasal Drug And Vaccine Delivery Device Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country/Region (2018-2023)
Table 33. Global Intranasal Drug And Vaccine Delivery Device Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023) & (K Units)
Table 36. Americas Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2018-2023)
Table 37. Americas Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2018-2023)
Table 39. Americas Intranasal Drug And Vaccine Delivery Device Sales by Type (2018-2023) & (K Units)
Table 40. Americas Intranasal Drug And Vaccine Delivery Device Sales by Application (2018-2023) & (K Units)
Table 41. APAC Intranasal Drug And Vaccine Delivery Device Sales by Region (2018-2023) & (K Units)
Table 42. APAC Intranasal Drug And Vaccine Delivery Device Sales Market Share by Region (2018-2023)
Table 43. APAC Intranasal Drug And Vaccine Delivery Device Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Region (2018-2023)
Table 45. APAC Intranasal Drug And Vaccine Delivery Device Sales by Type (2018-2023) & (K Units)
Table 46. APAC Intranasal Drug And Vaccine Delivery Device Sales by Application (2018-2023) & (K Units)
Table 47. Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023) & (K Units)
Table 48. Europe Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2018-2023)
Table 49. Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2018-2023)
Table 51. Europe Intranasal Drug And Vaccine Delivery Device Sales by Type (2018-2023) & (K Units)
Table 52. Europe Intranasal Drug And Vaccine Delivery Device Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Intranasal Drug And Vaccine Delivery Device
Table 60. Key Market Challenges & Risks of Intranasal Drug And Vaccine Delivery Device
Table 61. Key Industry Trends of Intranasal Drug And Vaccine Delivery Device
Table 62. Intranasal Drug And Vaccine Delivery Device Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Intranasal Drug And Vaccine Delivery Device Distributors List
Table 65. Intranasal Drug And Vaccine Delivery Device Customer List
Table 66. Global Intranasal Drug And Vaccine Delivery Device Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Intranasal Drug And Vaccine Delivery Device Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Intranasal Drug And Vaccine Delivery Device Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Intranasal Drug And Vaccine Delivery Device Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Intranasal Drug And Vaccine Delivery Device Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Intranasal Drug And Vaccine Delivery Device Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Intranasal Drug And Vaccine Delivery Device Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GlaxoSmithKline Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 81. GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 82. GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Main Business
Table 84. GlaxoSmithKline Latest Developments
Table 85. Teva Pharmaceuticals Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 87. Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Latest Developments
Table 90. Aptar Pharma Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 91. Aptar Pharma Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 92. Aptar Pharma Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Aptar Pharma Main Business
Table 94. Aptar Pharma Latest Developments
Table 95. UCB Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 96. UCB Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 97. UCB Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. UCB Main Business
Table 99. UCB Latest Developments
Table 100. Teleflex Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 101. Teleflex Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 102. Teleflex Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Teleflex Main Business
Table 104. Teleflex Latest Developments
Table 105. 3M Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 106. 3M Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 107. 3M Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. 3M Main Business
Table 109. 3M Latest Developments
Table 110. Bespak Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 111. Bespak Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 112. Bespak Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bespak Main Business
Table 114. Bespak Latest Developments
Table 115. OptiNose Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 116. OptiNose Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 117. OptiNose Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. OptiNose Main Business
Table 119. OptiNose Latest Developments
Table 120. Intersect Basic Information, Intranasal Drug And Vaccine Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 121. Intersect Intranasal Drug And Vaccine Delivery Device Product Portfolios and Specifications
Table 122. Intersect Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Intersect Main Business
Table 124. Intersect Latest Developments
List of Figures
Figure 1. Picture of Intranasal Drug And Vaccine Delivery Device
Figure 2. Intranasal Drug And Vaccine Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intranasal Drug And Vaccine Delivery Device Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Intranasal Drug And Vaccine Delivery Device Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Powder Delivery Device
Figure 10. Product Picture of Liquid Delivery Device
Figure 11. Product Picture of Pressurized Metered Dose Inhaler
Figure 12. Product Picture of Others
Figure 13. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type in 2022
Figure 14. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2018-2023)
Figure 15. Intranasal Drug And Vaccine Delivery Device Consumed in Respiratory Disorders
Figure 16. Global Intranasal Drug And Vaccine Delivery Device Market: Respiratory Disorders (2018-2023) & (K Units)
Figure 17. Intranasal Drug And Vaccine Delivery Device Consumed in Neurological Disorder
Figure 18. Global Intranasal Drug And Vaccine Delivery Device Market: Neurological Disorder (2018-2023) & (K Units)
Figure 19. Intranasal Drug And Vaccine Delivery Device Consumed in Vaccination
Figure 20. Global Intranasal Drug And Vaccine Delivery Device Market: Vaccination (2018-2023) & (K Units)
Figure 21. Intranasal Drug And Vaccine Delivery Device Consumed in Pain Management
Figure 22. Global Intranasal Drug And Vaccine Delivery Device Market: Pain Management (2018-2023) & (K Units)
Figure 23. Intranasal Drug And Vaccine Delivery Device Consumed in Others
Figure 24. Global Intranasal Drug And Vaccine Delivery Device Market: Others (2018-2023) & (K Units)
Figure 25. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2022)
Figure 26. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application in 2022
Figure 27. Intranasal Drug And Vaccine Delivery Device Sales Market by Company in 2022 (K Units)
Figure 28. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Company in 2022
Figure 29. Intranasal Drug And Vaccine Delivery Device Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Company in 2022
Figure 31. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Intranasal Drug And Vaccine Delivery Device Sales 2018-2023 (K Units)
Figure 34. Americas Intranasal Drug And Vaccine Delivery Device Revenue 2018-2023 ($ Millions)
Figure 35. APAC Intranasal Drug And Vaccine Delivery Device Sales 2018-2023 (K Units)
Figure 36. APAC Intranasal Drug And Vaccine Delivery Device Revenue 2018-2023 ($ Millions)
Figure 37. Europe Intranasal Drug And Vaccine Delivery Device Sales 2018-2023 (K Units)
Figure 38. Europe Intranasal Drug And Vaccine Delivery Device Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue 2018-2023 ($ Millions)
Figure 41. Americas Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country in 2022
Figure 42. Americas Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country in 2022
Figure 43. Americas Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
Figure 44. Americas Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2018-2023)
Figure 45. United States Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Intranasal Drug And Vaccine Delivery Device Sales Market Share by Region in 2022
Figure 50. APAC Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Regions in 2022
Figure 51. APAC Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
Figure 52. APAC Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2018-2023)
Figure 53. China Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country in 2022
Figure 61. Europe Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country in 2022
Figure 62. Europe Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
Figure 63. Europe Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2018-2023)
Figure 64. Germany Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2018-2023)
Figure 73. Egypt Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Intranasal Drug And Vaccine Delivery Device Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Intranasal Drug And Vaccine Delivery Device in 2022
Figure 79. Manufacturing Process Analysis of Intranasal Drug And Vaccine Delivery Device
Figure 80. Industry Chain Structure of Intranasal Drug And Vaccine Delivery Device
Figure 81. Channels of Distribution
Figure 82. Global Intranasal Drug And Vaccine Delivery Device Sales Market Forecast by Region (2024-2029)
Figure 83. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の鼻腔内治療薬＆ワクチン送達装置市場予測 2023年-2029年(Global Intranasal Drug And Vaccine Delivery Device Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の鼻腔内薬剤&ワクチン送達デバイス市場2023年：企業・地域・タイプ・用途別分析
  • 医療用埋め込み型薬物送達装置のグローバル市場予測2023-2029
  • ワクチンデリバリーデバイスの世界市場（2023年～2030年）：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆